FDA Accepts Eisai and Biogen’s Application for Monthly Maintenance Dosing of Alzheimer's Drug LEQEMBI

Eisai Co.,  and Biogen announced that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s Supplemental Biologics License Applicat...

June 10, 2024 | Monday | News
ASP Japan Secures Exclusive Sales Contract with PENTAX Medical for Innovative Endoscopy Solutions

ASP Japan LLC (hereinafter referred to as ASP Japan) was announced by HOYA Group PENTAX Europe GmbH ( hereinafter referred to as PENTAX Medical) and the ...

May 31, 2024 | Friday | News
AstraZeneca's TROPION-Lung01 Trial Reveals Datopotamab Delxtecan's Potential as New Treatment Option for Advanced Lung Cancer

TROPION-Lung01 Phase III trial had a local progressive or metastatic non-small cell lung cancer with at least one treatment history in the past ( Datopot...

May 29, 2024 | Wednesday | News
Astellas Pharma and Poseida Therapeutics Forge Research Collaboration to Develop Novel CAR-T Cell Therapies for Solid Tumors

Astellas Pharma  and Poseida Therapeutics, Inc.   announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos")...

May 02, 2024 | Thursday | News
Takeda's ADZYNMA® Receives Approval in Japan for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

    cTTP, an ultra-rare blood clotting disorder, presents life-threatening acute events and debilitating chronic symptoms. Untreated acute TTP ...

March 27, 2024 | Wednesday | News
MediciNova Receives Notice of Allowance for MN-166 Patent in Japan

MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ:MNOV) and the Tokyo Stock Exchange (Code Number: 4875), has receiv...

March 27, 2024 | Wednesday | News
Orchard Therapeutics Achieves Landmark FDA Approval for Lenmeldy™, Pioneering Gene Therapy for Early-onset Metachromatic Leukodystrophy

Orchard Therapeutics, now under the stewardship of Kyowa Kirin, announces a historic milestone as the U.S. Food and Drug Administration (FDA) grants approv...

March 19, 2024 | Tuesday | News
Beckman Coulter and Fujirebio to Develop Blood-based Neurodegenerative Disease Diagnostics

  In 2023, Beckman Coulter and Fujirebio entered into a collaboration agreement focused on new biomarkers aligned with recently approved monoclonal a...

March 13, 2024 | Wednesday | News
Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan BLA Accepted in U.S. for Advanced Nonsquamous NSCLC Treatment

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have announced the acceptance of their Biologics License Application (BLA) for datopotamab...

February 19, 2024 | Monday | News
Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)

  Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved...

February 16, 2024 | Friday | News
Ajinomoto Co. Expands Presence in Silicon Valley with Launch of Corporate Venture Capital Headquarters

The expansion into Silicon Valley marks a strategic move for Ajinomoto Co., which seeks to support and collaborate with innovators across four key growth a...

February 13, 2024 | Tuesday | News
Takeda Advances Global Phase 3 Trials of TAK-861 in Narcolepsy Type 1 Following Positive Phase 2b Results

Takeda  unveiled promising topline results from a comprehensive Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 (OX2R) agonist, in patien...

February 12, 2024 | Monday | News
Nikon Expands Global BioImaging Network with New Labs in USA and Japan

Nikon Instruments Inc. (Nikon) is pleased to announce the establishment of the Nikon BioImaging Lab Lexington in Massachusetts, USA, where it will provide ...

January 29, 2024 | Monday | News
Travere Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics, Inc. announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endot...

January 26, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in